Form 8-K - Current report:
SEC Accession No. 0001193125-08-126502
Filing Date
2008-06-02
Accepted
2008-06-02 15:17:21
Documents
2
Period of Report
2008-05-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 13385
2 CERTIFICATE OF AMENDMENT TO THE REGISTRANT'S CERTIFICATE OF INCORPORATION dex101.htm EX-10.1 3907
  Complete submission text file 0001193125-08-126502.txt   18898
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 08873682
SIC: 2836 Biological Products, (No Diagnostic Substances)